Back to UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

CGONCGON
9 quarters

Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCUBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in CG ONCOLOGY INC

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 761,807 shares of CGON (CG ONCOLOGY INC), worth $54.1M as of 2026-Q2. The position was decreased (-28.5% shares). CGON represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.

Current Value

$54.1M

Current Shares

761,807

Total Value Change

+$53.4M

Total Shares Change

+738,182

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
761,807
-28.5%
$54.1M0.0%$71.05
0
2026-Q1
Decreased
1.1M
-2.4%
$72.1M0.0%$60.55
0
2025-Q4
Increased
1.1M
+39.8%
$45.3M0.0%$40.17
39
2025-Q3
Decreased
780,302
-8.9%
$31.4M0.0%$39.08
0
2025-Q2
Increased
856,597
+377.6%
$22.3M0.0%$25.95
46
2025-Q1
Increased
179,363
+42.5%
$4.4M0.0%$26.42
36
2024-Q4
Increased
125,902
+496.1%
$3.6M0.0%$28.50
43
2024-Q3
Decreased
21,122
-10.6%
$796,9330.0%$37.87
0
2024-Q2
New
23,625
-
$745,8420.0%$31.57
34

Other major holders of CGON: RTW INVESTMENTS, LP, BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used